COPD activates bitter taste receptors, the target of asthma treatment

Published Date: 17 Mar 2023

Germany: Activation of bitter taste receptors opens lung pathways, making them potential targets for the treatment of chronic lung diseases...

Read Full News

Latest News

Pembrolizumab Favored Over Chemo for Pulmonary AEs

Researchers look at adverse effects beyond interstitial pneumonitis when comparing antibody monotherapy to chemotherapy in people with non-small cell lung cancer.

Air Trapping Predicts Pneumothorax After BLVR

Noninvasive analysis can help patients avoid in-hospital post-procedure monitoring.

Sanofi Says Rare Lung Disease Drug Outperforms Standard Care in Trial

(Corrects executive's name from Alaa Ahmed to Alaa Hamed in paragraphs 7 and 8)

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

Todays Updates

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

Drug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.

Todays Updates

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

Drug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.

Latest News

Researchers look at adverse effects beyond interstitial pneumonitis when comparing antibody monotherapy to chemotherapy in people with non-small cell lung cancer.

Noninvasive analysis can help patients avoid in-hospital post-procedure monitoring.

(Corrects executive's name from Alaa Ahmed to Alaa Hamed in paragraphs 7 and 8)

Integrating Multidisciplinary Insights Into Treatment Decisions in Resectable NSCLC

Optimizing HER2 Assessment and Treatment in Advanced NSCLC: From Guidelines to the Clinic

Managing Treatment-Related Adverse Events Associated With Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC

News All Time

Incidental Findings in Lung Screening Could Indicate Undiagnosed Cancers

However, acting on these findings will place additional burdens on health systems, experts say

Doc Gave Patients Recalled CPAPs 'Fixed' by His Own Children

Sleep medicine specialist was sentenced to a year in prison and will pay $350K in restitution

Cooking and Dementia Risk; High-Dose vs Standard-Dose Flu Shot

Also in TTHealthWatch: replacing the aortic valve in asymptomatic people

Alzheimer's Risk May Be Influenced by Flu Shots

High-dose vaccine tied to roughly 20% lower risk of Alzheimer's dementia

Here's How Many Doctors and Nurses Are Getting Flu or COVID Shots

Nurses in particular do not seem to be fans of the COVID-19 vaccine

Trump: 'It Was Me as a Doctor'; Lululemon PFAS Probe; Dick Vitale's Fifth Cancer Dx

Health news and commentary gathered by MedPage Today staff

Quiz Time: How Are Flu Shots and Alzheimer's Linked?

You passed medical training, now see if you can pass our weekly quiz

Doc Detained by Border Patrol; Lady Gaga Sick, Cancels Show; Sexy Chocolate Recall

Health news and commentary gathered by MedPage Today staff

Amoxicillin Alone Holds Up for Acute Sinusitis

Observational study supports efficacy, safety compared with amoxicillin-clavulanate

Novel KRAS Drug Shows 'Excellent' Efficacy in Tough-to-Treat Lung Cancer

Zoldonrasib ideal for further evaluation in KRAS G12D-mutant disease, expert says

Early Lung Cancer Data Show Why FDA Approved HER2 Agent in First-Line

Zongertinib in phase I trial showed sustained efficacy in aggressive disease

Undetected TB May Be Lurking in U.S. Hospitals, Ultrasensitive Assay Suggests

Findings of TB DNA will require larger studies to confirm clinical relevance, says researcher

Congresswoman Tied to COVID Fraud Resigns; DOD Ends Flu Vax Mandate; USPSTF Overhaul

Health news and commentary gathered by MedPage Today staff

If It's COVID, Paxlovid? Studies Suggest a Rethink These Days

In a post-pandemic landscape, the drug didn't top usual care at stopping hospitalization, death

Bronchial Casts: An Unusual Complication of Wildfire Smoke Inhalation

Case is a "graphic demonstration" of emergent, severe impacts of forest fires for everyday people

Portable Tuberculosis Diagnostic Tool Matched Traditional Tests' Results

The MiniDock MTB could expand access to molecular testing in peripheral health centers

Recommended News For You

How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs

Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.

Hypnotherapy may offer real benefits for cancer patient care

Research exposes far-reaching toll of financial hardship on patients with cancer

Distribution of fat could influence cancer risk, study suggests

Launch of the hereditary cancer clinic for precision oncology at Kokilaben Hospital.

Top Options Are Discovered Through Direct Comparison of 25 Migraine Drugs.

Recommended Articles For You

Innovative Approaches in Oncology for Modern Medicine 

Clinical Trends in Oncology in Clinical Decision-Making 

Oncologic Emergencies: Diagnosis and Treatment 

Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

An inhibitor of JAK1 exhibits "remarkable" activity in T-cell lymphoma.

2.

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

3.

Decrease seen in in situ breast cancer since 2009

4.

Should the UK introduce targeted prostate cancer screening? The case for and against

5.

Safe and acceptable telehealth suicide prevention program.

1.

The Immunotherapeutic and Targeted Revolution in Melanoma Management – A 2025 Perspective

2.

How EPCORITAMAB is Revolutionizing the Treatment of Cancer

3.

Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment

4.

All You Need To Know About Melanoma Maligna: Causes, Symptoms & Treatment

5.

Targeting Iron Recycling Pathways in Hematologic Disease

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

2.

The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

4.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

5.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot